Banned in Boston

April 6, 2009 by Chris Markuns

Massachusetts enacted the nation's strictest law governing industry payments to physicians. What does the so-called "gift ban" mean for the Commonwealth's medical devices sector?

Say goodbye to the promotional pen

Pharma is sexy. Big drugs, big money, big news. In the life sciences arena, perhaps only biotech commands a higher political and public profile.

So it isn’t surprising that the medical device industry’s groundbreaking inclusion in Massachusetts’ new code of conduct garnered relatively little attention.

But the new rules governing industry payments to physicians — the so-called "gift ban" — include provisions aimed at curbing what some call undue and improper influence by medical device manufacturers.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Features

Integrity Applications looks beyond optical sensors with its GlucoTrack Model DF-F, which uses ultrasonic, electromagnetic and thermal technology to measure physiological changes associated with blood glucose levels.

Former NBA player Jonathan Bender tries his hand at entrepreneurship, aiming to bring the physical therapy device he invented to the U.S. market.

Battelle engineering manager Melissa Masters tells MassDevice.com how insights ranging from national security to aeronautics can inform the creation of disruptive new medical devices.

The special sauce in contract research organization Ora Inc.'s recipe for ophthalmology trials is the eye care practice its founder started 30 years ago.

Animal rights advocacy group PETA holds a tiny stake in several medtech companies, taking frequent advantage of its shareholder rights to push changes in the way device makers experiment on animals.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp